AnandRathi

Baroda BNP Paribas Health and Wellness Fund-Reg(G)

EquitySectoral / Thematic

Last Updated NAV Date: 13 May 2026

3 Year Returns

N/A

NAV (₹)

9.7547

1 Day NAV Change

0.01%

No chart data available for this period.

Fund Details

Min. SIP Amount₹ 500
Min. Lumpsum Amount₹ 1000
AUM₹ 530.21 Cr
Expense Ratio2.46%
Lock-in PeriodNo Lock-in Period
Inception Date27 Jun 2025
Fund Age0 Yrs

Exit Load

Redemption/ switch out of units upto 10% of the units allotted before 1 year from date of allotment Exit load NIL. For redemption/switch out of units above 10% of units allotted within 1 year from the date of allotment 1.00% of applicable NAV. For redemption/switch out of units after 1 year from the date of allotment Nil.

Fund’s Investment Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

Calculate Your Mutual Fund Returns

Calculator

Returns Estimator

Estimation is based on the past performance

Enter Amount

₹

Select Duration

Yrs

1 Yr

30 Yrs

Expected Rate of Return

12%

8%

30%

The value of your investment after 5 Years will be

₹4,12,432

Invested Amount

₹3,00,000

Est. Returns

₹1,12,432

Scheme’s Historical Return

1 Month Return5.66%
3 Month Return4.57%
6 Month Return1.26%
1 Year Return-
3 Year Return-
5 Year Return-

Asset Allocation

AUM

₹1,33,309.00 Cr

Cash Holdings

21.45%

Equity

70.84%

Cash

21.45%

Debt

1.71%

Other

6%

Sector Holdings

Last Updated: 30 Apr 2026
SectorsAllocationWeightageValue (in Cr.)
Pharmaceuticals
69.69%₹ 369.53
Healthcare
19.52%₹ 103.491
Insurance
6.42%₹ 34.016
Retail
1.69%₹ 8.965
IT - Software
1.60%₹ 8.505
Miscellaneous
1.08%₹ 5.705

Stock Holdings

Last Updated: 30 Apr 2026
NameAllocationWeightageValue (in Cr.)Sector
Sun Pharma.Inds.
9.38%₹ 49.728Pharmaceuticals
Lupin
6.09%₹ 32.273Pharmaceuticals
Ipca Labs.
5.34%₹ 28.322Pharmaceuticals
Abbott India
5.28%₹ 27.979Pharmaceuticals
Torrent Pharma.
5.13%₹ 27.203Pharmaceuticals
Laurus Labs
4.78%₹ 25.322Pharmaceuticals
Fortis Health.
4.35%₹ 23.074Healthcare
Apollo Hospitals
4.32%₹ 22.91Healthcare
J B Chemicals &
4.24%₹ 22.477Pharmaceuticals
Astrazeneca Phar
4.03%₹ 21.354Pharmaceuticals

Fund Manager Details

Prior to this, he worked as Senior Fund Manager with BSL AMC. Before joining Birla, he worked as Head of Research with SBI Capital Markets and has worked in various capacities in equity research space in Motilal Oswal Securities, IDBI Capital Markets, SMIFS Securities, IIT Invest Trust & Lloyds Securities MMS

Risk-O-Meter

Very High Risk

Investors understand that their principal will be at Very High Risk

Risk Scale

Low
Moderately Low
Moderate
Moderately High
High
Very High

AMC Information

Baroda BNP Paribas Mutual Fund

Funds Managed

48

Assets Managed

₹ 55,006.90 Cr

Contact Details

www.barodabnpparibasmf.in
service@barodabnpparibasmf.in
022 69209600

Registered Address

201 (A) 2nd Floor, A wing, Crescenzo,C-38 & 39, G Block, Bandra-Kurla Complex, Mumbai - 400051.

Managing Director

Sanjay Kumar Grover

Chief Executive Officer

Sanjay Kumar Grover

Compliance Officer

Nisha Sanjeev

Mutual Funds Calculators

View All Calculators

SIP Calculator

>

Lumpsum Calculator

>

Mutual Fund Calculator

>

CAGR Calculator

>

ELSS Calculator

>

Explore Mutual Funds by Types

Equity Funds

Debt Funds

Hybrid Funds

Other Funds

Open NFOs

View All NFOs

Motilal Oswal Contra Fund - Regular (G)

Open-Close08 May - 22 May
Min. Investment₹500

Motilal Oswal Contra Fund - Regular (IDCW)

Open-Close08 May - 22 May
Min. Investment₹500
Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

The Net Asset Value (NAV) of Baroda BNP Paribas Health and Wellness Fund-Reg(G) is updated at the end of every business day. You can check the latest NAV in the header section of this page.
You can invest in Baroda BNP Paribas Health and Wellness Fund-Reg(G) online through the Anand Rathi AR Invest app or website. Simply log in, complete your KYC if not already done, and choose between SIP or Lumpsum investment modes.
Exit load varies by scheme. For Baroda BNP Paribas Health and Wellness Fund-Reg(G), please refer to the "Fund Details" section above to see if any exit load applies for early redemptions.
Mutual funds are generally suitable for long-term wealth creation. However, suitability depends on your individual risk appetite and financial goals. You should review the riskometer and fund performance before investing.
Once you invest, you can track your portfolio performance, NAV changes, and transaction history in real-time through the AR Invest dashboard.

Download the AR Invest App

5000+ Schemes
Personalized Solutions
Expert Insights
Google Play
App Store
TradeMobi
Company Logo

Address

Registered and Corporate Office:

Express Zone A Wing, 10th Floor, Western Express Highway, Goregaon East, Mumbai 400063.
Contact No. 022-62817000

Channels

Others

Quick Links

Stock Directory

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Popular on Anand Rathi

Anand Rathi Share and Stock Brokers Ltd.
SEBI Registration No.: INZ000170832 (BSE-949 | NSE-06769 | MSEI-1014 | MCX-56185 | NCDEX-1252), CDSL & NSDL: IN-DP-437-2019. *Research Analyst - INH000000834. PMS: INP000000282 is Registered under "Anand Rathi Advisors Limited" | MBD-INM000010478 is Registered under "Anand Rathi Advisors Limited"| NBFC is Registered under "Anand Rathi Global Finance Limited" Regn. No.: B-13.01682 | Insurance is Registered under "Anand Rathi Insurance Brokers Ltd." License No. 175. Insurance Corporate Agent: CA1048 (This registration shall be valid from 04-Jun-2025 to 03-Jun-2028).

Anand Rathi International Ventures (IFSC) Private Limited.
SEBI Registration No.: INZ000292939 (INDIA INX Member Code: TM - 5064 | NSE IX Member Code: TM -10048, IIBX Member Code: TM – 2011), IIDI DP ID 350071 AND Registration No.: IFSCA/DP/2022-23/007, IFSCA/CMI/Distributor/2023-24/0002. CIN No.: U65999GJ2016PTC094915. For any complaints email at Ifscgrievance@rathi.com. Regulator: International Financial Services Centres Authority (IFSCA)- https://www.ifsca.gov.in/

Disclaimer:

Equity: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

The securities are quoted as an example and not as a recommendation.

Mutual Funds: Mutual Fund investments are subject to market risks, read all scheme related documents carefully before Investing. AMFI-Registered Mutual Fund Distributor: ARN-4478 (Initial Registration 4th Feb, 2003 & Valid From 2nd April, 2025 - 1st April, 2028) : Anand Rathi Share and Stock Brokers Ltd. | ARN-111569: Anand Rathi Wealth Limited | ARN-100284: AR Digital Wealth Private Limited.

IPO: Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO.

*Third Party products: All third-party products like PMS, Mutual Funds, Fixed Income Products, IBS, Bonds, AIFs are not Exchange traded product and "ARSSBL" is just acting as distributor. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.

MTF: MTF is subject to the provisions of SEBI Cir. CIR/MRD/DP/54/2017 dt June 13, 2017 & terms and conditions mentioned in rights and obligations statement issued by the ARSSBL

Investment Baskets: Baskets are not Exchange traded product, all disputes with respect to this activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.

Research Analyst: The views expressed in this website accurately reflect the personal views of the analyst(s) about the subject securities or issuers and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the research analyst(s). The advertisment are bound by stringent internal regulations and also legal and statutory requirements of the Securities and Exchange Board of India (hereinafter "SEBI").

Certification: Registration granted by SEBI and certification from NISM is in no way a guarantee of performance of the intermediary or provides any assurance of returns to investors.

*Award Winning Research: Anand Rathi Share and Stock Brokers Limited (Research Analyst) was awarded as "Best Equity Advisor" at World BFSI Congress & Awards 2022

*Client Data: Client data shown on this website is as on 31st March 2025

Trading View: Anand Rathi has partnered with TradingView for its charting technology. A global platform offering heatmaps, STOCK SCREENERS and market data.

By submitting this form, I hereby provide my explicit consent to be contacted by Anand Rathi Group and its associate companies via phone call, SMS, email, or WhatsApp for information related to products and services, even if I am registered on DND.

Attention Investors:

  • For all communication related to vulnerability reporting, security alerts, or any other suspicious activity related to cyber security, contact priyanksheth@rathi.com/+91-22-62811514"
  • For any complaints email at grievance@rathi.com, For DP related queries/complaints email at dp@rathi.com
  • For any Mutual Fund-related complaints, please email customersupport@rathi.com.
  • For further escalation, you may contact mf@rathi.com.
  • Filing of complaints on SCORES – Easy & quick a. Register on SCORES portal b. Mandatory details for filing complaints on SCORES: I. Name, PAN, Address, Mobile Number, Email ID c. Benefits: I. Effective communication ii. Speedy redressal of the grievances.
  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 and BSE vide notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 dated August 31, 2020 and other guidelines issued from time to time in this regard
  • Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
Prevent Unauthorized Transactions in your demat account → Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL.•No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.•KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.•Prevent Unauthorized Transactions in your demat account → Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL.•No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.•KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.